|
|
Time |
Source |
|
Announcement
|
|
| 20 May 2022 |
8:45 am |
GNW
|
|
|
Saniona AB |
Saniona provides update on ongoing review of tesofensine in Mexico |
| 30 Apr 2022 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona publishes its Annual Report for 2021 |
| 27 Apr 2022 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona Changes Date of Annual Report for 2021 |
| 25 Apr 2022 |
5:15 pm |
GNW
|
|
|
Saniona AB |
Notice of Saniona AB annual shareholders’ meeting |
| |
3:25 pm |
GNW
|
|
|
Saniona AB |
Saniona Announces Refocused Strategy on Ion Channel R&D and Restructuring of Board of Directors and Executive Management Team |
| 29 Mar 2022 |
3:00 pm |
GNW
|
|
|
Saniona AB |
Saniona Announces Strategic Program Prioritization and Restructuring to Streamline Operational Costs |
| 24 Mar 2022 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona Initiates Positron Emission Tomography (PET) Stage of SAN711 Phase 1 Clinical Trial |
| 21 Mar 2022 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona ion channel research collaboration with Boehringer Ingelheim advances to next stage |
| 01 Mar 2022 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona to participate in multiple upcoming investor conferences |
| 24 Feb 2022 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona publishes its year-end report for 2021 |
| 10 Feb 2022 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona Initiates Multiple Ascending Dose Stage of SAN711 Phase 1 Clinical Trial |
| 05 Jan 2022 |
3:45 pm |
GNW
|
|
|
Saniona AB |
Saniona to participate in multiple upcoming virtual investor conferences |
| 28 Dec 2021 |
4:00 pm |
GNW
|
|
|
Saniona AB |
Saniona Initiates Phase 2b Clinical Trial of Tesomet for Prader-Willi Syndrome |
| 02 Dec 2021 |
9:45 pm |
GNW
|
|
|
Saniona AB |
Saniona Chairman J. Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market |
| 25 Nov 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona AB’s Nomination Committee for the Annual General Meeting 2022 |
| 18 Nov 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona publishes its interim report for the third quarter of 2021 |
| 17 Nov 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona Initiates Phase 2b Clinical Trial of Tesomet for Hypothalamic Obesity |
| 18 Oct 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona completes submission of manufacturing data for Tesomet capsules to U.S. FDA |
| 06 Oct 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona to participate in multiple upcoming virtual investor conferences |
| 16 Sep 2021 |
4:50 pm |
GNW
|
|
|
Saniona AB |
Saniona appoints Robert Hoffman to Board of Directors as Chair of the Audit Committee |
| |
4:45 pm |
GNW
|
|
|
Saniona AB |
Bulletin from the Saniona AB extraordinary shareholders’ meeting on September 16, 2021 |
| 15 Sep 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona appoints Wendy Dwyer as Chief Business Officer |
| 26 Aug 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona publishes its interim report for the second quarter of 2021 |
| 20 Aug 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Notice of Saniona AB extraordinary shareholders’ meeting to elect new member of the board of directors |
| 26 Jul 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity |
| 14 Jul 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona secures SEK 87 million ($10 million) non-dilutive term loan |
| 30 Jun 2021 |
11:45 am |
GNW
|
|
|
Saniona AB |
Saniona Initiates Phase 1 Clinical Trial of SAN711 |
| 29 Jun 2021 |
3:15 pm |
GNW
|
|
|
Saniona AB |
Bulletin from the Saniona AB extraordinary shareholders’ meeting on June 29, 2021 |
| 25 Jun 2021 |
6:45 pm |
GNW
|
|
|
Saniona AB |
Saniona provides update on ongoing review of tesofensine in Mexico |
| 08 Jun 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona to Present Preclinical Data on SAN711 at the 7th Congress of the European Academy of Neurology |
| 26 May 2021 |
6:30 pm |
GNW
|
|
|
Saniona AB |
Notice of Saniona AB extraordinary shareholders’ meeting |
| |
5:30 pm |
GNW
|
|
|
Saniona AB |
Bulletin from the Saniona AB annual shareholders’ meeting on May 26, 2021, and information regarding planned extraordinary shareholders’ meeting |
| |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona publishes its interim report for the first quarter of 2021 |
| 20 May 2021 |
7:30 pm |
GNW
|
|
|
Saniona AB |
Saniona Hosts Research and Development (R&D) Day on Proprietary Ion Channel Drug Discovery Engine and Pipeline Programs |
| 12 May 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona to Host Research and Development (R&D) Day on Leveraging Ion Channel Targeting Expertise for Rare Diseases |
| 10 May 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona Launches New Video Series to Highlight the Impact of Prader-Willi Syndrome and Hypothalamic Obesity on Patients and Caregivers |
| 30 Apr 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Change in numbers of shares and votes in Saniona AB (publ) |
| 29 Apr 2021 |
4:55 pm |
GNW
|
|
|
Saniona AB |
Saniona publishes its Annual Report for 2020 |
| 26 Apr 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona to Present at Multiple Upcoming Investor Conferences |
| 23 Apr 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Notice of Saniona AB annual shareholders’ meeting |
| 22 Apr 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona announces outcome of TO3 warrant exercise |
| |
12:00 am |
GNW
|
|
|
Saniona AB |
Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA |
| 19 Apr 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona Announces Partnership with the Foundation for Prader-Willi Research (FPWR) to Support its Prader-Willi Syndrome (PWS) Clinical Trial with Tesomet |
| 14 Apr 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB |
Saniona to Present Preclinical Data on SAN903 at the ASPET Annual Meeting at Experimental Biology 2021 |
| 12 Apr 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona Completes Sale of Remaining Shares in Scandion Oncology |
| 31 Mar 2021 |
7:00 am |
GNW
|
|
|
Saniona AB |
Saniona announces that the exercise period of warrants of series TO3 begins on April 6, 2021 |
| 19 Mar 2021 |
4:30 pm |
GNW
|
|
|
Saniona AB |
Saniona Chairman J. Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market |
| 17 Mar 2021 |
7:00 am |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona publishes its year-end report for 2020 |
| 15 Mar 2021 |
12:00 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona Announces Oral Presentation of Tesomet Data in Hypothalamic Obesity at ENDO 2021 |
| 10 Mar 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona to Present at the Oppenheimer 31st Annual Healthcare Conference |
| 08 Mar 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona Receives Feedback from U.S. FDA Providing a Regulatory Path Forward for Tesomet in Hypothalamic Obesity |
| 03 Mar 2021 |
12:00 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Prader-Willi Syndrome |
| 22 Feb 2021 |
10:59 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona postpones 2020 year-end financial report due to restatement and re-audit of prior period financial statements in line with U.S. PCAOB audit standards |
| 25 Jan 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona received approximately USD $2.9 million (SEK 24.2 million) upfront payment in connection with Cadent Therapeutics transaction |
| 07 Jan 2021 |
1:00 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona to present at three upcoming investor conferences |
| 21 Dec 2020 |
1:00 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona Appoints Chief Legal Officer and Chief Technical Operations Officer to Its Executive Team |
| 17 Dec 2020 |
9:15 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3% |
| 16 Dec 2020 |
7:00 am |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona’s Ownership Stake in Scandion Oncology Reduced Below 5% Following Scandion’s Successful Rights Issue |
| 30 Nov 2020 |
7:00 am |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona publishes its interim report for the third quarter 2020 |
| 26 Nov 2020 |
3:00 pm |
GNW
|
|
|
Saniona AB (0RQJ) |
Saniona AB’s Nomination Committee for the Annual General Meeting 2021 |